What Is NAD+?
NAD+ is central to cellular energetics, but human evidence is mainly biochemical and early physiologic rather than proof of longevity or disease-prevention benefit.
The biology
NAD+ is a metabolic cofactor essential to cellular energetics. It is not a stimulant, hormone, or cure-all.
Human NAD+ literature largely measures changes in NAD-related metabolites, tolerability, and physiologic markers rather than validated clinical outcomes such as disease prevention or lifespan extension.
What patients should know
Delivery route, dose, medication history, pregnancy status, and goals should be reviewed for safety and expectation-setting before use.
Unlike incretin therapy for defined obesity or diabetes endpoints, NAD+ does not have an established patient-selection framework tied to a specific morbidity, mortality, or disease-prevention outcome.
How Pacific RX frames it
Pacific RX frames NAD+ requests as safety-reviewed, patient-initiated wellness interest rather than evidence-backed treatment for a defined disease, metabolic-health endpoint, cognition endpoint, or longevity outcome.